Indian Government Amends Rules to Debar Pharma Firms Submitting Fabricated Data

The Union health and family welfare ministry in India has amended rules to debar pharmaceutical firms found submitting fake or fabricated data, a move aimed at strengthening the integrity of the regulatory system.